Laboratory testing in hemophilia: Impact of factor and non-factor replacement therapy on coagulation assays.

Peyvandi, Flora; Kenet, Gili; Pekrul, Isabell; Pruthi, Rajiv K; Ramge, Peter; Spannagl, Michael

Peyvandi, Flora; Kenet, Gili; Pekrul, Isabell; Pruthi, Rajiv K; Ramge, Peter; Spannagl, Michael.

Afiliação

Peyvandi F; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Kenet G; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Pekrul I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pruthi RK; The Israeli National Hemophilia Center and Thrombosis Unit, The Amalia Biron Thrombosis Research Institute, Sheba Medical Center, Tel Hashomer, Israel.
Ramge P; Hämostaseologie, Campus Innenstadt, Klinikum der Universität München, München, Germany.
Spannagl M; Division of Hematology, Department of Internal Medicine, Mayo Clinic Rochester, Rochester, MN, USA.

J Thromb Haemost ; 18(6): 1242-1255, 2020 06.

Article em En | MEDLINE | ID: mdl-32115865

Assuntos

Hemofilia A; Hemofilia B; Técnicas de Laboratório Clínico; Fator IX/genética; Fator VIII; Hemofilia A/diagnóstico; Hemofilia A/tratamento farmacológico; Hemofilia B/diagnóstico; Hemofilia B/tratamento farmacológico; Humanos; Qualidade de Vida

Palavras-chave

blood coagulation factors; emicizumab; factor IX; factor VIII; hemophilia A; hemophilia B

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofilia B / Hemofilia A Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google